中文摘要：

目的 观察疏血通针联合低分子肝素、纤溶酶治疗进展型脑梗死的临床效果.方法 将60例脑梗死患者随机分成治疗组和对照组,对照组患者给予疏血通针及基础治疗；治疗组加用低分子肝素及纤溶酶治疗;评价治疗前和治疗后2周的神经功能缺损评分以及临床疗效.结果 治疗后2周,治疗组神经功能缺损评分与对照组比较,改善有显著性（P＜0.01）,用药后2周与用药前两组疗效比较,改善有显著性（P＜0.05）.结论 疏血通针联合低分子肝素、纤溶酶能有效阻止进展型脑梗死病情的进展,改善神经功能缺损,且副作用小.

英文摘要：

Objective To assess the clinical efficacy of shuxuetong in combination with low molecular heparin,fibri- nolytie enzyme on the progressive cerebral infarction. Methods 60 patients with cerebral infarction were randomly di- vided into treatment group ang control group.In the control group was treated with shuxuetong and foundation treat- ment;The treatment group was treated with shuxuetong,low molecular heparin,fibrinolysin and foundation treatment.It was in order to evaluate loss of nerve function before an after treatment,and clinical effect two weeks after treatment. Results Loss of nerve function two weeks after treatment in treatment group was much better than the control guoup, with significant difference （P〈0.01）.There was great imprevement of the treatment group in curaive effect after treament two weeks （P〈0.05）. Conclusion The curative effect of shuxuetong combined therapy with low molecular heparin,fibri- nolytic enzyme on the progressive cerebral infarction is defnite and can stop the discase progression and improve the neurological deficits effectively with less adverse reactions.